Area of research
Infectious Diseases · Epidemiology
Research interest
Research focused on Virology and Lassa virus, with related work in Lassa fever, Ebola virus, Nucleoprotein. Notable publications include 'Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot', 'Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea', and 'Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs'.
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial
Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys
A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates
Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
Immune parameters and outcomes during Ebola virus disease
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Exonuclease Domain of the Lassa Virus Nucleoprotein Is Critical To Avoid RIG-I Signaling and To Inhibit the Innate Immune Response